We are live on ! Find out more
TCM

Tang Capital Management Portfolio holdings

AUM $1.97B
1-Year Est. Return 125.1%
This Fund
S&P 500
This Quarter Est. Return
+17.27%
1 Year Est. Return
+125.1%
3 Year Est. Return
+474.48%
5 Year Est. Return
+595.08%
10 Year Est. Return
+2,831.44%
AUM
$631M
AUM Growth
+$304M
Cap. Flow
+$236M
Cap. Flow %
37.46%
Top 10 Hldgs %
100%
Holding
6
New
1
Increased
–
Reduced
2
Closed
2

Top Buys

Rank Stock Value
1
ODT
Odonate Therapeutics, Inc. Common Stock
ODT
+$288M

Top Sells

Rank Stock Value
1
RXDX
Ignyta, Inc.
RXDX
+$39.5M
2
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$8.4M
3
HRTX icon
Heron Therapeutics
HRTX
+$2.89M
4
BGMS
Bio Green Med Solution Inc
BGMS
+$1.02M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ODT
1
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
$305M 48.33%
+12,202,338
New +$288M
HRTX icon
2
Heron Therapeutics
HRTX
$86.3M
$153M 24.28%
8,466,377
-177,362
-2% -$2.89M
LJPC
3
DELISTED
La Jolla Pharmaceutical Company
LJPC
$111M 17.54%
3,440,419
– –
RXDX
4
DELISTED
Ignyta, Inc.
RXDX
$62.2M 9.85%
2,328,279
-2,435,323
-51% -$39.5M
BMRN icon
5
BioMarin Pharmaceuticals
BMRN
$11.5B
– –
-90,215
Closed -$8.4M
BGMS
6
Bio Green Med Solution Inc
BGMS
$5.05M
– –
-8
Closed -$1.02M

Similar funds

HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
SGAM
Smith Group Asset Management Dallas, Texas $1.96B AUM 43.61% 1-Year Est. Return
CCA
Checchi Capital Advisers Beverly Hills, California $1.98B AUM 19.17% 1-Year Est. Return
FWTB
First Western Trust Bank Denver, Colorado $1.98B AUM 1.62% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
RMCM
Reynders McVeigh Capital Management Boston, Massachusetts $1.98B AUM 23.37% 1-Year Est. Return
FC
Finepoint Capital Boston, Massachusetts $1.95B AUM 45.61% 1-Year Est. Return
SC
Syon Capital San Francisco, California $1.99B AUM 22.67% 1-Year Est. Return

Tang Capital Management's Q4 2017 Portfolio in Review

As of Q4 2017, Tang Capital Management held 6 positions worth $631M, up 93% from $328M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Tang Capital Management deployed $236M of net new capital in Q4 2017, opening 1 new position. Its largest new stake was Odonate Therapeutics, Inc. Common Stock: 12,202,338 shares worth $305M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

On the sell side, the largest reduction was Ignyta, Inc., an estimated $39.5M trimmed.

  • Tang Capital Management's largest Q4 2017 buy was Odonate Therapeutics, Inc. Common Stock: 12,202,338 shares worth $305M.
  • Tang Capital Management's biggest Q4 2017 reduction was Ignyta, Inc., cutting an estimated $39.5M.
  • Tang Capital Management fully exited BioMarin Pharmaceuticals in Q4 2017, selling an estimated $8.4M.
  • Tang Capital Management's ten largest holdings make up 100% of its $631M portfolio in Q4 2017.
  • Tang Capital Management opened 1 new position and closed 2 in Q4 2017.
  • Tang Capital Management's portfolio value rose 93% quarter-over-quarter to $631M.

Based on Tang Capital Management's 13F filing for Q4 2017, filed 14 Feb 2018.